Dasatrue 70mg Tablet
By Dasatrue
Rx
60 Tablet in a Bottle

Composition
Dasatinib(70mg)

Manufacturer - Cipla Ltd
Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013

Expires on or after
July, 2025
About Dasatrue 70mg Tablet
Dasatrue 70mg Tablet is a medication primarily used in the treatment of blood cancer known as chronic myeloid leukaemia. It is specifically intended for patients whose condition has not responded to other leukemia medications or who are unable to tolerate those medications due to side effects.
When taking Dasatrue 70mg Tablet, it is essential to follow your doctor's instructions diligently. The dosage and frequency of administration will be determined by your healthcare provider based on your treatment needs, which may evolve over time. Consistency is key, so try to take the tablet at the same time each day for optimal benefits.
It may take some time for the medication to demonstrate its effectiveness, which means patience is crucial. It is strongly advised not to discontinue the treatment unless instructed by your doctor, as improper use or overconsumption can lead to severe side effects. Common side effects include nausea, vomiting, abdominal pain, and rash. However, in some instances, it may result in effects such as increased heart rate and fluctuations in blood pressure, necessitating a consultation with your doctor.
Regular monitoring, including blood pressure checks and blood tests, will likely be part of your treatment regimen to ensure the medication's safety and efficacy. It is vital to avoid taking antacids within two hours of consuming Dasatrue 70mg Tablet. Additionally, this medication may lower blood cell counts, increasing the risk of infections, underscoring the importance of routine blood tests.
Given the potential for interactions with other medications, it is crucial to inform your healthcare team about all the medicines you are currently using. Dasatrue 70mg Tablet is not recommended during pregnancy or while breastfeeding, and precautions should be taken to avoid driving if experiencing dizziness or blurred vision while on the treatment.
Benefits
Dasatrue 70mg Tablet, containing Dasatinib, is a medication used in the treatment of blood cancer, specifically Chronic Myeloid Leukemia (CML). This form of cancer affects the blood-forming tissues, leading to a decrease in the body's ability to fight infections. Dasatrue 70mg Tablet works by targeting and killing cancer cells, as well as preventing their growth and multiplication. By inhibiting the action of abnormal proteins that cause the multiplication of cancerous cells, Dasatrue 70mg Tablet helps to stop the abnormal growth of cancer cells, thus reducing the spread of cancer to other parts of the body. It is essential to consult with your doctor about the risks and benefits of this potent and toxic medicine. During treatment with Dasatrue 70mg Tablet, it is advised to avoid alcohol consumption and ensure adequate hydration by drinking plenty of water. Overall, Dasatrue 70mg Tablet offers a targeted approach to treating blood cancer, providing potential benefits in managing the progression of the disease and improving overall health outcomes for patients.
How to use the Dasatrue 70mg Tablet
To use Dasatrue 70mg Tablet effectively, it is essential to follow your doctor's instructions regarding the dosage and duration. Swallow the tablet whole with a glass of water, and do not chew, crush, or break it. You can take Dasatrue 70mg Tablet with or without food, but it is recommended to take it at the same time each day to maintain consistency. It's crucial not to exceed the prescribed dose of the medicine to avoid any potential risks or side effects. Remember to consult your doctor for proper guidance on how to use Dasatrue 70mg Tablet for your specific condition.
Uses of Dasatrue 70mg Tablet
Dasatrue 70mg Tablet is prescribed for the treatment of blood cancers such as Chronic myeloid leukaemia and Philadelphia chromosome-positive chronic myeloid leukemia. It is also used for Philadelphia chromosome-positive acute lymphoblastic leukemia. Dasatrue 70mg Tablet plays a crucial role in managing these conditions effectively.
What conditions Dasatrue 70mg Tablet treats?
Dasatrue 70mg Tablet is used in the treatment of Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia and Ph+ acute lymphoblastic leukemia. These are types of blood cancer that affect the bone marrow's ability to produce normal white blood cells, leading to symptoms such as fatigue, fever, weight loss, and loss of appetite. In these conditions, specific chromosome abnormalities create proteins that trigger the production of abnormal white blood cells, compromising the body's ability to fight infections. Dasatrue 70mg Tablet helps to target and manage these abnormal cells, supporting the treatment of these leukemia types.
Should you consult a doctor?
If you experience abdominal pain, anemia, breathing problems, fatigue, fever, headache, infection, low blood platelets, musculoskeletal pain, nausea, rash, or vomiting while taking Dasatrue 70mg Tablet for chronic myeloid leukaemia, you should consult your doctor. Additionally, if you notice increased heartbeat, low or high blood pressure, dizziness, or blurred vision, it is important to seek medical advice promptly. Remember to inform your healthcare team about all medications you are using, as interactions can occur. Regular blood tests are essential to monitor blood cell counts due to the medicine's effects. Contact your doctor if side effects persist or if you have concerns, as most effects resolve over time. Furthermore, it is crucial to avoid driving if you experience dizziness or blurred vision during treatment. Dasatrue 70mg Tablet is not recommended during pregnancy or breastfeeding due to potential risks.
Side effects of Dasatrue 70mg Tablet
When taking Dasatrue 70mg Tablet, you may experience some side effects. These side effects are usually mild and temporary, as your body gets used to the medication. However, if they continue or cause you concern, it's best to consult your doctor. Common side effects of Dasatrue 70mg Tablet can include abdominal pain, anemia (low red blood cell count), breathing difficulties, fatigue, fever, headache, infections, low blood platelet levels, musculoskeletal pain (related to bones, muscles, or joints), nausea, rash, vomiting, diarrhea, decreased platelet count, edema (swelling), back pain, dizziness, skin rash, and difficulty breathing. In some cases, side effects such as gastrointestinal bleeding and myalgia (muscle pain) may also occur. Always seek medical advice if you experience persistent or worrying side effects while using Dasatrue 70mg Tablet.
Safety advice

liver
Dasatrue 70mg Tablet is considered safe for patients with liver disease, and it is not necessary to adjust the dose when using this medication.

kidney
Dasatrue 70mg Tablet is considered safe for use in patients with kidney disease, and dose adjustment may not be necessary. Consult your doctor for more guidance.

alcohol
Consult your doctor when consuming alcohol with Dasatrue 70mg Tablet.

driving
Caution should be taken when driving while using Dasatrue 70mg Tablet, as it may cause side effects like dizziness and blurred vision that can affect your ability to drive safely.

pregnancy
Dasatrue 70mg Tablet should not be used during pregnancy as it poses a risk to the developing baby. However, in rare life-threatening situations, a doctor may prescribe it if benefits outweigh risks. Consult your doctor before use.

breastfeeding
Dasatrue 70mg Tablet is not recommended for breastfeeding mothers as it may be harmful to the baby, causing toxicity.
Consumption warning before consuming Dasatrue 70mg Tablet
Before consuming Dasatrue 70mg Tablet, make sure to avoid it if you have any known allergies to the medication or its ingredients. Inform your doctor about your complete medical history, including current medications, to prevent any potential side effects or interactions. It is crucial to disclose any existing liver/kidney disease, diabetes, cardiac issues, high blood pressure, or gastrointestinal disorders to your doctor as the use of Dasatrue 70mg Tablet may result in severe side effects for these conditions. Possible side effects include myelosuppression, fluid retention, gastrointestinal bleeding, QT prolongation, congestive heart failure, left ventricular dysfunction, and myocardial infarction. This medicine is linked to embryo-fetal toxicity, so if you are pregnant or planning to conceive, consult your doctor before initiating treatment. Nursing mothers should discontinue breastfeeding while using this medication. Dasatrue 70mg Tablet is only recommended for children over the age of one under a doctor's guidance. Avoid alcohol and smoking during the course of treatment to prevent adverse effects.
Disease interactions
Before taking Dasatrue 70mg Tablet, it is crucial to inform your doctor about any existing kidney or liver disease, gastrointestinal disorders, diabetes, and cardiac disorders. These conditions can potentially interact with the medication and may require special attention or dosage adjustments to ensure the safe and effective use of Dasatrue 70mg Tablet. It is important for your doctor to be aware of your medical history to make informed decisions regarding the treatment plan with Dasatrue 70mg Tablet.
What if you forgot to take Dasatrue 70mg Tablet?
If you forget to take a dose of Dasatrue 70mg Tablet, simply skip the missed dose and resume your regular dosing schedule. It's important not to take a double dose to make up for the missed one. Just continue with your next scheduled dose as usual. Remember to follow the prescribed dosing instructions to ensure the effectiveness of the medication.
Related lab tests
Related Lab Tests:
When taking Dasatrue 70mg Tablet, it is important to monitor certain lab tests to ensure the medication is working effectively and to watch for any potential side effects. The following lab tests are recommended for patients on Dasatrue 70mg Tablet:
1. Bcr-Abl Gene Translocation (Qualitative): This test helps to detect the presence of the Bcr-Abl gene, which is associated with certain types of leukemia. Monitoring this gene can help assess the response to treatment with Dasatrue 70mg Tablet.
2. Bcr-Abl Gene Translocation (Quantitative): In addition to the qualitative test, the quantitative test provides a more detailed measurement of the Bcr-Abl gene, allowing for a more precise evaluation of treatment response.
3. Complete Blood Count (CBC): This test measures the levels of different types of blood cells, including red blood cells, white blood cells, and platelets. It helps to monitor for any potential abnormalities that may occur as a result of taking Dasatrue 70mg Tablet.
4. Peripheral Smear Examination: This test involves examining a sample of blood under a microscope to assess the size, shape, and number of blood cells. It can provide valuable information about the effects of Dasatrue 70mg Tablet on blood cell morphology.
Regular monitoring of these lab tests can help healthcare providers ensure that Dasatrue 70mg Tablet is being well-tolerated and is effectively managing the condition for which it is prescribed.
Additional Information
Habit Forming | No |
Chemical Class | Pyrimidine and Thiazole Derivetive |
Therapeutic Class | - |
Action Class | Tyrosine kinase inhibitors |
FAQs
Disclaimer
The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.
₹9350
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024